INM-089 IVT formulation selected for continued developmentDemonstrated successful delivery at doses up to 10 times the ...

Rheumatoid arthritis (RA) is an autoimmune disorder affecting millions worldwide, causing chronic inflammation, debilitating ...

Regeneron Pharmaceuticals Inc.’s stock rose 3% early Tuesday, after the company posted better-than-expected fourth-quarter ...

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

A team of scientists has developed a groundbreaking approach using specially designed peptides to improve drug formulations.

VANCOUVER - InMed Pharmaceuticals Inc. (NASDAQ: INM), a small-cap biotech company with a market capitalization of $2.21 million, has announced the selection of an intravitreal (IVT) formulation, ...

Bajaj Health has also extended the offer for Pimavanserin to several leading pharma companies to ensure availability in ...

Scientists have developed a groundbreaking approach using specially designed peptides to improve drug formulations. This innovative method significantly enhances anti-tumor efficacy. A team of ...

A new formulation for medicine that does not need cold chain support, new air cargo friendly ultra-cold storage, and the FDA ...

Susvimo 100 mg/mL for intravitreal use via ocular implant is a refillable implant surgically inserted into the eye during a ...